Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Accéder directement au contenu
Article Dans Une Revue BMC Medicine Année : 2016

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

William J Blot
  • Fonction : Auteur
Stephen Thibodeau
  • Fonction : Auteur
Adam S Kibel
  • Fonction : Auteur
Cezary Cybulski
  • Fonction : Auteur
Lisa Cannon-Albright
  • Fonction : Auteur
Jong Park
  • Fonction : Auteur
Radka Kaneva
  • Fonction : Auteur
Hardev Pandha
  • Fonction : Auteur
The Practical Consortium
  • Fonction : Auteur

Résumé

Background Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach. Methods We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample. Results In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64–0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43–91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91–1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90–0.98), but not with disease grade. Conclusions Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease.
Fichier principal
Vignette du fichier
s12916-016-0602-x.pdf (904.99 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

cea-04551279 , version 1 (18-04-2024)

Licence

Paternité

Identifiants

Citer

Carolina Bonilla, Sarah J Lewis, Richard M Martin, Jenny L Donovan, Freddie C Hamdy, et al.. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Medicine, 2016, 14 (1), pp.66. ⟨10.1186/s12916-016-0602-x⟩. ⟨cea-04551279⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More